|
AHMED MMFATIMA FANWER MKALDAWSARI MFALSAIDAN YSMALFAIZ SAHAQUE AAZ AALHAZZANI K., CHEM PHYS LIPIDS., vol. 233, November 2020 (2020-11-01), pages 105003
|
|
ARDUIN M.COLL: "Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids", BIOORG MED CHEM, 2007
|
|
BARNES PJ: "The cytokine network in asthma and chronic constructive pulmonary disease", J CLIN INVEST., 2008
|
|
BUSSE WW.LEMANSKE RFJR. ASTHMA, N ENGL J MEAN., vol. 344, no. 5, 2001, pages 350 - 62
|
|
COX BMCOLI: "The IUPHAR compendium of receptor characterization and classification", 2000, IUPHAR MEDIA LTD, article "Opoid transactors"
|
|
D'AGOSTINO BMARROCCO GDE NARDO MCALO GGUERRINI RGALLELLI LADVENIER CROSSI F.: "Activation of the nocicepin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux", BR J PHARMACOL., 2005
|
|
D'AGOSTINO BORLOTTI DCALO GON NRUSSIAN MGUERRINI RDE NARDO MMAZZEO FCANDELETTI SROSSI F: "Nociceptin modates bronchoconstriction induced by sensory nerve activation in mouse lung", AM J RESPIR CELL MOL BIOL., 2010
|
|
DENHAM S.COLI: "Meta-analysis of genome-wide linkage studies of asthma and related traits", RESPIR RES., 2008
|
|
ELEONORE FROHLICHSHARAREH SALAR-BEHZADI: "Orai inhalation for delivery of proteins and peptides to the lungs", EUR J PHARM BIOPHARM, 2021
|
|
EUN LEEYOUNG-HO KIMHYUN-JU CHOJISUN YOONSUNGSU JUNGSONG-I YANGHYUNG YOUNG KIMJI-WON KWONJU-HEE SEOHYO-BIN KIM: "Clinical phenotypes of bronchial hyperresponsiveness in school-aged children", ANN ALLERGY ASHMA IMMUNOL, 2018
|
|
FRANCESCO MENZELLA, GIULIA GHIDONI, CARLA GALEONE, SILVIA CAPOBELLI, CHIARA SCELFO, NICOLA COSIMO FACCIOLONGO.: "Immune aspects related to viral infections in severe Ashma and the role of Omalizumab", BIOMEDICINES, 2021
|
|
G DECREASED G LAMBERT.: "Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic", BR J ANAESTHETH, 2018
|
|
HAKIM, T. S.SUGIMORI, K.FERRARIO, L.: "Analysis of the double occlusion which provides four pressure gradients", EUR. RESPR. J., 1996
|
|
HANS JACOB L KOEFOEDANNELIES M ZWITSERLOOTJUDITH M VONKGERARD H KOPPELMAN: "Asthma, bronchial hyperresponsiveness, allergy and lung function development until earlv adulthood: A systemic literature review", PEDIATR ALLERGY IMMUNOL., 2021
|
|
HIRAO A., IMAI A., SUGIE Y., TAMURA T., SHIMOKAWA H., TOIDE K.: "Pharmacological properties of a novel nociceptin/orphanin FQ receptor agonist, 2-(3,5-dimethylpiperazin-1 -yl)-1 -[1 -(1 -methylcyclooctyl)piperidin-4-yl]-LH -benzimidazole, with anxiolytic potential.", EUR J PHARMACOL., 2008
|
|
IRMELI LINDSTROMJUSSI LANTTOKIRSI KARVALASATU SOINIKATRIINA YLINENHILLE SUOJALEHTOKATRI SUURONEN: "Infections and exposure events in acute and subacute irritant-induced asthma.", ENVIRON MEAN OCCUP, 2021
|
|
KAROL WTOREKANNA JANECKA: "Potential of Nociceptin/Orphanin FQ peptide Analysts for Drug Development", CHEM BIODIVERS., 2021
|
|
KAWASHIMA Y.NIWA THANDA T.TAKEUCHI H.IWAMOTO T.ITOH Y.: "Preparation of expanded-release spherical micro-matrix of ibuprofen with acrylic polymer by the emulsion-solvent diffusion method for improving bioavailability", CHEM PHARM BULL., 1989
|
|
KIGUCHI NDING HKISHIOKA SKO MC: "Nociceptin/Orphanin FQ peptide receptor-related Ligands as novel Analgesics", CURR TOP MEAN CHEM, 2020
|
|
KOICHI HIROSERIFUMI IWATATOMOHIRO TAMACHIHIROSHI NAKAJIMA: "Allergies airway inflammation: key players beyond the Th2 celi pathway", IMMUNOL REV., 2017
|
|
LADURON PM.: "Axonal transport of opiate transporters in capsaicin-sensitive neurones", BRAIN RES
|
|
LAMBERT DG: "The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential", NATURE, 2008
|
|
LOW MRISSE PANALINE EDECREASE GGUERRINI RADJUST DADVENIER C: "Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation", PEPTIDES, 2005
|
|
MA C, WU M, YE WANG W, WANG W, HUANG Y, PAN X, WU C., DRUG DELIV TRANSL RES, vol. II, no. 3, June 2021 (2021-06-01), pages 1218 - 1235
|
|
MARTA PERIZ, FRANCISCO J PEREZ-CANO, MARIA J RODRIGUEZ-LAGUNAS TRINITAT CAMBRAS, SANTIAGO PASTOR-SOPLIN, IVAN BEST, MARGARIDA CAST: "Development and Characterization of an Allergies Ashma Rat Model for Interventional Studies", J MOL SCI, 2020
|
|
MCLEOD R L ET AL: "Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig", PHARMACOLOGY, S. KARGER AG, CH, vol. 71, no. 3, 1 July 2004 (2004-07-01), pages 143 - 149, XP009130512, ISSN: 0031-7012, DOI: 10.1159/000077448
*
|
|
MCLEOD RLTULSHIAN DBBOLSER DC ET AL.: "Pharmacological profile of the NOP agonist and cough suppressant agent SCH 486757 (8-[bis(2-chlorophyyl)methyl]-3-(2-pyridinyl)-8-azabicyclo[3.2.1]octan-3-ol) in preclinical models", EUR J PHARMACOL, 2010
|
|
MODIL JSPASTERNAK GW.: "The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family", PHARMACOL REV., 2001
|
|
MOHAMED BRAHIM ERRAHMANI, KARIMA FELLAGUE CHEBRA, ZOHOR MESSAOUDI: "Multidimensional analysis of genetic background and environmental factors: Cases of atopy in asthmatic children", ARCH PEDATR., 2020
|
|
MORENO-BAUTISTA G.KAM C.TAM.: "Evaluation of dialysis membrane process for quantifying the in vitro drug-release front colloidal drug carriers", SURF COLLOIDS. TO PHYSICOCHEM. ENG. ASP, 2011
|
|
NGAN CHENG LOONG ET AL: "Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, GERMANY, vol. 8, no. 5, 7 June 2018 (2018-06-07), pages 1527 - 1544, XP036578457, ISSN: 2190-393X, [retrieved on 20180607], DOI: 10.1007/S13346-018-0550-4
*
|
|
ON NROVIEZZO FMATTEIS MLANARO ACALO GGUERRINI RDE GRUTTOLA LRANGE GCIRINO GROSSI F: "Harmful/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice", AM J PHYSIOL LUNG CELI MOL PHYSIOL., 2013
|
|
PEEBLES RS JR ET AL.: "Inflammatory Pathways in the Pathogenesis of Ashma", GIN CHEST MED., 2019
|
|
PEISER CUNDEM BJFISCHER A: "Harmful effects in the aindays", PEPTIDES, 2000
|
|
PRAGYA PRASANNASHWETA RATHEEARUN UPADHYAYSULAKSHANA SULAKSHANA: "Nanotherapeutics in the treatment of acute respiratory distress syndrome", LIFE SKIING, 2021
|
|
PUGLIA COFFER A.CARBON CBONINA F.PIGNATELLO R.PUGLISI G.: "Lipid nanocarriers (LNC) and their applications in ocular drug delivery", CURR MED CHEM., 2015
|
|
PUGLIA CSANTONOCITO DOBSTACLE CMARIA SOMMELA ECAMPIGLIA PCARBONE CDRAGO FPIGNATELLO RBUCOLO C.: "Ocular formulation based on Palmitoylethanolamide-loaded Nanostructured lipid carriers: Technological and pharmacological Profile", NANOMATERIALS (BASEL, 2020
|
|
RANGE GSORRENTINO RMATTEIS MMALGIERI G, MRUSSIAN TPTERLIZZI MROVIEZZO FROSSI FPINTO AFATTORUSSO R: "Harmful reducers the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness", CLIN EXP ALLERGY., 2017
|
|
ROUGET CINCLUDING YYD'AGOSTINO BFAISY CNALINE EBARDOU MADVENIER C: "Nociceptin inobits airway microvascular leakage induced by intra-hexophageal instillation HCI", BR J PHARMACOL., 2004
|
|
SINGH SRON ND'AGOSTINO BBRIGHTLING CELAMBERT DG.: "The effects of nocicepptin peptide (N/OFQ)-receptor (NOP) system activation in the airways", PEPTIDES, 2013
|
|
SINGH SRON NMATTEIS MRANGE GMCDONALD JSAUNDERS RWOODMAN LURBANEK KDE ANGELIS ADE PALMA R: "Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness presenting a novel target for the treatment of asthma", BR J PHARMACOL., 2016
|
|
SUARTHANA ECOLI: "Risks for the Development of outcomes related to Occupational Allergies", ENVIRON MEAN OCCUP, 2008
|
|
TARTALION GRANGE G, MRUSSIAN TPLIPARULO AESPOSITO RMIRRA SFILOSA RROVIEZZO FPOWDER FD'AGOSTINO B.: "Harmful/Orphanin Fq in inflammation and remoding of the small airways in experimental model of airway hyperresponsive", PHYSIOL REP., 2018
|
|
UHLIG, S.WOLLEN, L.: "An improved setup for the isolated improved rat lung", J. PHARMACOL. TOXICOL. METHODS, vol. 31, 1994, XP023802889, DOI: 10.1016/1056-8719(94)90047-7
|
|
W SCHRODERD G LAMBERTM C KOT KOCH.: "Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists", BR J PHARMACOL, 2014
|
|
WANG J J ET AL: "Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ELSEVIER AMSTERDAM, NL, vol. 38, no. 2, 10 September 2009 (2009-09-10), pages 138 - 146, XP026494702, ISSN: 0928-0987, [retrieved on 20090708], DOI: 10.1016/J.EJPS.2009.06.008
*
|
|
WANG JHI-JOUNG ET AL: "Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles", JOURNAL OF MICROENCAPSULATION., vol. 26, no. 8, 5 November 2009 (2009-11-05), GB, pages 734 - 747, XP055860417, ISSN: 0265-2048, Retrieved from the Internet <URL:https://www.tandfonline.com/doi/pdf/10.3109/02652040902746679?needAccess=true> DOI: 10.3109/02652040902746679
*
|
|
WEBER S ET AL: "Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 86, no. 1, 2 September 2013 (2013-09-02), pages 7 - 22, XP028625479, ISSN: 0939-6411, DOI: 10.1016/J.EJPB.2013.08.013
*
|
|
WOODCOCK AMCLEOD RLSADEH JSMITH JA.: "The efficiency of a NOP1 agonist (SCH486757) in subacute cough", LUNG, 2010
|